Pik3ca-related Overgrowth

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-02-04
Clinical Trial Update: Trial of Taselisib in Overgrowth [Phase 1, Phase 2]
A phase 1/2 trial of taselisib for PIK3CA-related overgrowth has been terminated.